Related Experiment Video
Updated: Sep 5, 2025

04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
900
Re-do Operation Using a Robotic System due to Locoregional Recurrence after Initial Thyroidectomy for Thyroid Cancer
Dong Gyu Kim1, Kwangsoon Kim2, Ji-Eun Lee3
1Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
Scientific Reports
|July 7, 2022
Summary
Robotic re-do surgery is a feasible option for recurrent thyroid cancer, offering good outcomes and improved cosmesis. This minimally invasive approach shows comparable results to traditional methods for locoregional recurrence.
Area of Science:
- Surgical Oncology
- Robotic Surgery
- Endocrinology
Background:
- Locoregional recurrent thyroid cancer often necessitates re-operation.
- Re-do thyroid surgery presents unique surgical challenges due to scar tissue and altered anatomy.
- Minimally invasive techniques are being explored to improve outcomes and reduce morbidity in re-do thyroid surgery.
Purpose of the Study:
- To evaluate the feasibility and outcomes of robotic-assisted re-do surgery for locoregional recurrent thyroid cancer.
- To assess the safety, efficacy, and cosmetic advantages of the trans-axillary robotic approach in this patient population.
Main Methods:
- A retrospective analysis of 65 patients who underwent re-do robotic surgery for recurrent papillary thyroid carcinoma via a trans-axillary approach.
- Procedures included completion total thyroidectomy (CTT), modified radical neck dissection (mRND), or both.
- Data collected included operative times, complication rates, oncologic outcomes, and patient satisfaction.
Main Results:
- The study included completion total thyroidectomy (CTT) in 26 cases, CTT with modified radical neck node dissection (mRND) in 16, and mRND in 23.
- Transient hypocalcemia occurred in 26.2% of patients, permanent hypocalcemia in 4.6%, and one case of recurrent laryngeal nerve (RLN) injury.
- One patient experienced structural recurrence during a median follow-up of 50.7 months, indicating favorable oncologic control.
Conclusions:
- Re-do robotic surgery using the trans-axillary approach is a viable alternative for managing locoregional recurrent thyroid cancer.
- This technique offers comparable oncologic outcomes and morbidity to conventional methods, with the added benefit of superior cosmetic results.
- Robotic re-do surgery enhances patient satisfaction without compromising safety or efficacy in recurrent thyroid cancer management.

